Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 5 de 5
Filtrer
Plus de filtres











Base de données
Gamme d'année
1.
Proc Natl Acad Sci U S A ; 118(48)2021 11 30.
Article de Anglais | MEDLINE | ID: mdl-34815340

RÉSUMÉ

Common fragile sites (CFSs) are difficult-to-replicate genomic regions that form gaps and breaks on metaphase chromosomes under replication stress. They are hotspots for chromosomal instability in cancer. Repetitive sequences located at CFS loci are inefficiently copied by replicative DNA polymerase (Pol) delta. However, translesion synthesis Pol eta has been shown to efficiently polymerize CFS-associated repetitive sequences in vitro and facilitate CFS stability by a mechanism that is not fully understood. Here, by locus-specific, single-molecule replication analysis, we identified a crucial role for Pol eta (encoded by the gene POLH) in the in vivo replication of CFSs, even without exogenous stress. We find that Pol eta deficiency induces replication pausing, increases initiation events, and alters the direction of replication-fork progression at CFS-FRA16D in both lymphoblasts and fibroblasts. Furthermore, certain replication pause sites at CFS-FRA16D were associated with the presence of non-B DNA-forming motifs, implying that non-B DNA structures could increase replication hindrance in the absence of Pol eta. Further, in Pol eta-deficient fibroblasts, there was an increase in fork pausing at fibroblast-specific CFSs. Importantly, while not all pause sites were associated with non-B DNA structures, they were embedded within regions of increased genetic variation in the healthy human population, with mutational spectra consistent with Pol eta activity. From these findings, we propose that Pol eta replicating through CFSs may result in genetic variations found in the human population at these sites.


Sujet(s)
Sites fragiles de chromosome/génétique , DNA-directed DNA polymerase/métabolisme , DNA-directed DNA polymerase/physiologie , Lignée cellulaire , Fragilité des chromosomes/génétique , Fragilité des chromosomes/physiologie , ADN/génétique , Altération de l'ADN/génétique , DNA polymerase III/métabolisme , Réparation de l'ADN/génétique , Réparation de l'ADN/physiologie , Réplication de l'ADN/physiologie , Variation génétique/génétique , Instabilité du génome/génétique , Humains , Antigène nucléaire de prolifération cellulaire/métabolisme
2.
PLoS Genet ; 15(5): e1008169, 2019 05.
Article de Anglais | MEDLINE | ID: mdl-31100062

RÉSUMÉ

The Pol32 protein is one of the universal subunits of DNA polymerase δ (Pol δ), which is responsible for genome replication in eukaryotic cells. Although the role of Pol32 in DNA repair has been well-characterized, its exact function in genome replication remains obscure as studies in single cell systems have not established an essential role for Pol32 in the process. Here we characterize Pol32 in the context of Drosophila melanogaster development. In the rapidly dividing embryonic cells, loss of Pol32 halts genome replication as it specifically disrupts Pol δ localization to the nucleus. This function of Pol32 in facilitating the nuclear import of Pol δ would be similar to that of accessory subunits of DNA polymerases from mammalian Herpes viruses. In post-embryonic cells, loss of Pol32 reveals mitotic fragile sites in the Drosophila genome, a defect more consistent with Pol32's role as a polymerase processivity factor. Interestingly, these fragile sites do not favor repetitive sequences in heterochromatin, with the rDNA locus being a striking exception. Our study uncovers a possibly universal function for DNA polymerase ancillary factors and establishes a powerful system for the study of chromosomal fragile sites in a non-mammalian organism.


Sujet(s)
Sites fragiles de chromosome/physiologie , DNA polymerase III/génétique , DNA polymerase III/métabolisme , Animaux , Sites fragiles de chromosome/génétique , Fragilité des chromosomes/génétique , Fragilité des chromosomes/physiologie , Réparation de l'ADN , Réplication de l'ADN/génétique , Réplication de l'ADN/physiologie , DNA-directed DNA polymerase/génétique , Protéines de Drosophila/génétique , Protéines de Drosophila/métabolisme , Drosophila melanogaster/métabolisme , Protéine du syndrome X fragile/génétique , Mutagenèse , Signaux de localisation nucléaire/métabolisme , Liaison aux protéines
3.
Nat Commun ; 6: 7094, 2015 May 11.
Article de Anglais | MEDLINE | ID: mdl-25959793

RÉSUMÉ

Recurrent genomic instability in cancer is attributed to positive selection and/or the sensitivity of specific genomic regions to breakage. Among these regions are fragile sites (FSs), genomic regions sensitive to replication stress conditions induced by the DNA polymerase inhibitor aphidicolin. However, the basis for the majority of cancer genomic instability hotspots remains unclear. Aberrant oncogene expression induces replication stress, leading to DNA breaks and genomic instability. Here we map the cytogenetic locations of oncogene-induced FSs and show that in the same cells, each oncogene creates a unique fragility landscape that only partially overlaps with aphidicolin-induced FSs. Oncogene-induced FSs colocalize with cancer breakpoints and large genes, similar to aphidicolin-induced FSs. The observed plasticity in the fragility landscape of the same cell type following oncogene expression highlights an additional level of complexity in the molecular basis for recurrent fragility in cancer.


Sujet(s)
Sites fragiles de chromosome/physiologie , Fragilité des chromosomes/physiologie , Fibroblastes/physiologie , Instabilité du génome , Oncogènes/physiologie , Lignée cellulaire tumorale , Sites fragiles de chromosome/génétique , Fragilité des chromosomes/génétique , Délétion de gène , Régulation de l'expression des gènes/physiologie , Humains , Famille multigénique , Oncogènes/génétique , Plasmides
5.
Nature ; 470(7332): 120-3, 2011 Feb 03.
Article de Anglais | MEDLINE | ID: mdl-21258320

RÉSUMÉ

Common fragile sites have long been identified by cytogeneticists as chromosomal regions prone to breakage upon replication stress. They are increasingly recognized to be preferential targets for oncogene-induced DNA damage in pre-neoplastic lesions and hotspots for chromosomal rearrangements in various cancers. Common fragile site instability was attributed to the fact that they contain sequences prone to form secondary structures that may impair replication fork movement, possibly leading to fork collapse resulting in DNA breaks. Here we show, in contrast to this view, that the fragility of FRA3B--the most active common fragile site in human lymphocytes--does not rely on fork slowing or stalling but on a paucity of initiation events. Indeed, in lymphoblastoid cells, but not in fibroblasts, initiation events are excluded from a FRA3B core extending approximately 700 kilobases, which forces forks coming from flanking regions to cover long distances in order to complete replication. We also show that origins of the flanking regions fire in mid-S phase, leaving the site incompletely replicated upon fork slowing. Notably, FRA3B instability is specific to cells showing this particular initiation pattern. The fact that both origin setting and replication timing are highly plastic in mammalian cells explains the tissue specificity of common fragile site instability we observed. Thus, we propose that common fragile sites correspond to the latest initiation-poor regions to complete replication in a given cell type. For historical reasons, common fragile sites have been essentially mapped in lymphocytes. Therefore, common fragile site contribution to chromosomal rearrangements in tumours should be reassessed after mapping fragile sites in the cell type from which each tumour originates.


Sujet(s)
Acid anhydride hydrolases/génétique , Sites fragiles de chromosome/génétique , Fragilité des chromosomes/physiologie , Réplication de l'ADN/physiologie , Protéines tumorales/génétique , Origine de réplication/génétique , Lignée cellulaire , Cassure de chromosome , Fragilité des chromosomes/génétique , Réplication de l'ADN/génétique , Fibroblastes , Gènes suppresseurs de tumeur , Locus génétiques/génétique , Humains , Lymphocytes/métabolisme , Modèles biologiques , Spécificité d'organe
SÉLECTION CITATIONS
DÉTAIL DE RECHERCHE